Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.39

+1.2%

1:06 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (483)	7/8/1998 5:04:00 PM
From: Anthony Wong	Read Replies (4) of 1722

TOKYO (Nikkei)--Major Japanese pharmaceuticals companies have begun developing so-called 'lifestyle' drugs, such as products to help the obese lose weight or smokers kick the habit, The Nihon Keizai Shimbun Thursday morning edition reported. Eisai Co. (ESALF or 4523) plans to develop an obesity drug in cooperation with Knoll AG, part of Germany's BASF AG (G.BAS) group. The company hopes to beat rivals to the market with such a treatment by 2005. Takeda Chemical Industries Ltd. (J.TKD or 4502) will work with Pharmacia & Upjohn Inc. (PNU) to develop a chewing gum designed to help smokers quit. An incontinence drug marketed by Yamanouchi Pharmaceutical Co. (J.YMP or 4503) earned Y30.3 billion in sales for the company in fiscal 1997, to become one of the company's mainstay products. Pfizer Pharmaceuticals Inc., Japan arm of Pfizer Inc. (PFE), is set to file an application with the Health Ministry for approval to market Viagra, Pfizer's impotence treatment. (END) DOW JONES NEWS 07-08-98 10:29 AM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next